Ipamorelin vs Sermorelin: Comparative GHSR-1a and GHRH-R Receptor Research

Ipamorelin vs Sermorelin: Comparative GHSR-1a and GHRH-R Receptor Research In vitro research overview of Ipamorelin selective GHSR-1a (class A GPCR) Gq/calcium mobilisation in cell-based assay systems. For laboratory research use only. Ipamorelin vs Sermorelin: Comparative GHSR-1a and GHRH-R Receptor Research In Vitro Research Overview Ipamorelin and sermorelin represent distinct classes of peptide ligands that interact with different receptor systems in growth hormone signalling pathways. Ipamorelin functions as a selective growth hormone secretagogue receptor 1a (GHSR-1a) agonist, while sermorelin operates through growth hormone-releasing hormone receptor (GHRH-R) activation. Both compounds demonstrate unique receptor pharmacology profiles in cell-based assay systems, making them valuable tools for investigating growth hormone regulatory mechanisms in controlled laboratory environments. Published in vitro research characterises their molecular interactions, binding affinity profiles, and downstream pathway engagement in defined cell model systems. These peptides serve as research tools for examining receptor selectivity, signal transduction cascades, and comparative pharmacological properties within growth hormone-related receptor families. Ipamorelin Receptor Pharmacology and Mechanism of Action GHSR-1a Receptor Binding and Activation Ipamorelin demonstrates selective binding to GHSR-1a receptors, a class A G-protein coupled receptor that couples primarily to Gq/11 signalling pathways. Competitive radioligand binding assays reveal high-affinity interactions with GHSR-1a, with IC50 values consistently demonstrating potent receptor occupancy in nanomolar ranges. Functional cell-based assays utilising Chinese hamster ovary (CHO) cells transfected with human GHSR-1a show robust calcium mobilisation responses following ipamorelin exposure. Downstream Signalling Pathways Following GHSR-1a activation, ipamorelin initiates Gq/11-mediated phospholipase C (PLC) activation, resulting in inositol trisphosphate (IP3) and diacylglycerol (DAG) production. This cascade triggers calcium release from intracellular stores and protein kinase C (PKC) activation. Fluorescent calcium indicator assays demonstrate dose-dependent intracellular calcium increases in GHSR-1a-expressing cell lines, with EC50 values typically ranging in the nanomolar range. Receptor Selectivity Profile Receptor binding panels reveal ipamorelin's selectivity for GHSR-1a over related receptor systems. Cross-reactivity studies demonstrate minimal binding affinity for GHRH-R, somatostatin receptors, or other peptide hormone receptors at physiologically relevant concentrations. This selectivity profile makes ipamorelin a valuable research tool for isolating GHSR-1a-specific signalling mechanisms. Sermorelin Receptor Pharmacology and Mechanism of Action GHRH-R Binding Characteristics Sermorelin, a truncated analogue of growth hormone-releasing hormone (GHRH 1-29), exhibits high-affinity binding to GHRH receptors. Saturation binding studies in pituitary adenylyl cyclase-activating polypeptide (PACAP)-responsive cell lines demonstrate specific binding with Kd values in the nanomolar range. The compound maintains the critical amin